Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug

被引:48
作者
Chen, Yiyin [1 ,2 ,3 ]
Yang, Xiaomin [1 ,2 ,3 ]
Zhao, Lin [5 ]
Almasy, Laszlo [6 ]
Garamus, Vasil M. [4 ]
Willumeit, Regine [4 ]
Zou, Aihua [1 ,2 ,3 ]
机构
[1] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China
[2] E China Univ Sci & Technol, Shanghai Key Lab Funct Mat Chem, Shanghai 200237, Peoples R China
[3] E China Univ Sci & Technol, Inst Appl Chem, Shanghai 200237, Peoples R China
[4] Helmholtz Zentrum Geesthacht, Inst Mat Res, Ctr Mat & Coast Res, D-21502 Geesthacht, Germany
[5] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou 215123, Peoples R China
[6] Wigner Res Ctr Phys, Inst Solid State Phys & Opt, H-1525 Budapest, Hungary
关键词
Nanostructured lipid carrier; Docetaxel; SANS; SAXS; Cytotoxicity; NANOPARTICLES SLN; PHASE-II; DELIVERY; DOCETAXEL; CANCER;
D O I
10.1016/j.colsurfa.2014.04.032
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The aim of this study was to prepare a stable nanostructured lipid carrier (NLC) with biocompatible lipids and surfactants (Pluronic F68 and Cremophor EL) by high-pressure homogenization (HPH). Surface tension measurements were used to choose the suitable ratio between Pluronic F68 and Cremophor EL. Hydrophobic anticancer drug docetaxel (DTX) was used as an active pharmaceutical ingredient (API). The mean particle size of docetaxel loaded nanostructured lipid carrier (DTX-NLC), as determined by dynamic light scattering (DLS), was between 120 nm and 250 nm during the storage period of 30 days, with the entrapment efficiency decreasing from (60.5 +/- 5.0)% to (55.3 +/- 4.5)%, while zeta potential was slightly changed from (-43.19 +/- 3.6) mV to (-40.12 +/- 4.3) mV. Transmission electron microscopy (TEM) showed that some of DTX-NLCs have elongated shape. Small angle neutron scattering (SANS) demonstrated that DTX-NLC in solution contained dense core with perfectly smooth surface, while blank NLC had dense core but rough surface. The blank NLC and DTX-NLC showed cubic crystalline structure according to small angle X-ray scattering (SAXS). Wide angle X-ray diffraction (XRD) showed that adding of DTX increased the crystallinity of the NLC. Cytotoxicity was studied by MTT assay against Hela cells. The data suggested that blank NLC was biocompatible with HeLa cells while the DTX-NLC was more cytotoxic than pure DTX at the same drug concentration. DTX-NLC could be taken up into the cells more than pure DTX, which could be attributed to the better solubility of DTX after loading into NLC. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 49 条
[1]   Characterization of the nonlamellar cubic and HII structures of lipid A from Salmonella enterica serovar Minnesota by X-ray diffraction and freeze-fracture electron microscopy [J].
Brandenburg, K ;
Richter, W ;
Koch, MHJ ;
Meyer, HW ;
Seydel, U .
CHEMISTRY AND PHYSICS OF LIPIDS, 1998, 91 (01) :53-69
[2]  
Carsten O., 2002, INT J PHARMACEUT, V237, P119
[3]  
Carsten S., 2010, EUR J PHARM BIOPHARM, V77, P350
[4]   Role of target geometry in phagocytosis [J].
Champion, JA ;
Mitragotri, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) :4930-4934
[5]   DOCETAXEL IS A MAJOR CYTOTOXIC DRUG FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE CLINICAL SCREENING COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER [J].
CHEVALLIER, B ;
FUMOLEAU, P ;
KERBRAT, P ;
DIERAS, V ;
ROCHE, H ;
KRAKOWSKI, I ;
AZLI, N ;
BAYSSAS, M ;
LENTZ, MA ;
VANGLABBEKE, M .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :314-322
[6]   Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel [J].
Cho, Hyun-Jong ;
Yoon, Hong Yeol ;
Koo, Heebeom ;
Ko, Seung-Hak ;
Shim, Jae-Seong ;
Lee, Ju-Hee ;
Kim, Kwangmeyung ;
Kwon, Ick Chan ;
Kim, Dae-Duk .
BIOMATERIALS, 2011, 32 (29) :7181-7190
[7]   Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx [J].
Copper, M. P. ;
M, Triesscheijn ;
Tan, I. B. ;
Ruevekamp, M. C. ;
Stewart, F. A. .
CLINICAL OTOLARYNGOLOGY, 2007, 32 (03) :185-189
[8]   DOCETAXEL [J].
CORTES, JE ;
PAZDUR, R .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2643-2655
[9]   Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery [J].
Date, Abhijit A. ;
Vador, Nimish ;
Jagtap, Aarti ;
Nagarsenker, Mangal S. .
NANOTECHNOLOGY, 2011, 22 (27)
[10]   Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC) [J].
Fang, Jia-You ;
Fang, Chia-Lang ;
Liu, Chi-Hsien ;
Su, Yu-Han .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) :633-640